Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Mary J. Christoph"'
Autor:
William L. Baker, Mukul Sharma, Alexander Cohen, Mario Ouwens, Mary J. Christoph, Bruce Koch, Timothy E. Moore, Garrett Frady, Craig I. Coleman
Publikováno v:
PLoS ONE, Vol 19, Iss 5 (2024)
Externí odkaz:
https://doaj.org/article/a85a730a71a148258d7b956c55019554
Autor:
Gregory J. Fermann, Brooks D. Cash, Nayantara Coelho‐Prabhu, Marc Maegele, Roland Bingisser, Vinay Sehgal, Alexander T. Cohen, Anna Hundt Golden, Jon Russo, Mark Price, Allen Mangel, Bruce Koch, Mary J. Christoph, Truman J. Milling Jr.
Publikováno v:
Journal of the American College of Emergency Physicians Open, Vol 4, Iss 5, Pp n/a-n/a (2023)
Abstract Objective To define and contextualize life‐threatening gastrointestinal (GI) bleeding in the setting of factor Xa (FXa) inhibitor therapy and to derive a consensus‐based, clinically oriented approach to the administration of FXa inhibito
Externí odkaz:
https://doaj.org/article/1270a691872e4c78bfdff0c178ab6aa6
Autor:
James M. Williams, Belinda Lovelace, Mary J. Christoph, Suying Li, Haifeng Guo, Madison Hoover, Craig I. Coleman
Publikováno v:
Journal of the American College of Emergency Physicians Open, Vol 4, Iss 3, Pp n/a-n/a (2023)
Abstract Objective To characterize the burden of illness associated with oral factor Xa (FXa) inhibitor‐related bleeding in the US Medicare population. Methods This retrospective cohort study used the full 20% Medicare random sample claims database
Externí odkaz:
https://doaj.org/article/b234e6f95f164e549d0ec7424fb3e0ab
Autor:
Olivia S. Costa, Stuart J. Connolly, Mukul Sharma, Jan Beyer-Westendorf, Mary J. Christoph, Belinda Lovelace, Craig I. Coleman
Publikováno v:
Critical Care, Vol 26, Iss 1, Pp 1-13 (2022)
Abstract Background Andexanet alfa is approved (FDA “accelerated approval”; EMA “conditional approval”) as the first specific reversal agent for factor Xa (FXa) inhibitor-associated uncontrolled or life-threatening bleeding. Four-factor proth
Externí odkaz:
https://doaj.org/article/5a95a8a8d12246ddbc13b48e098b4962
Autor:
Craig I. Coleman, Mauricio Concha, Bruce Koch, Belinda Lovelace, Mary J. Christoph, Alexander T. Cohen
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
ObjectiveTo develop a composite score for predicting functional outcome post–intracerebral hemorrhage (ICeH) using proxy measures that can be assessed retrospectively.MethodsData from the observational ERICH study were used to derive a composite sc
Externí odkaz:
https://doaj.org/article/1dd38eaaabda47d78aa531dabd2e752b
Autor:
Olivia S. Costa, Mark J. Alberts, Mary J. Christoph, Belinda Lovelace, Jonathon Rocco, Craig I. Coleman
Publikováno v:
Health Sciences Review, Vol 5, Iss , Pp 100057- (2022)
Objectives: To perform a systematic review of studies evaluating prognostic factors (proxy measures) to predict patients’ post-stroke functional outcome status recommended by clinical guidelines. Materials and methods: MEDLINE and Embase databases
Externí odkaz:
https://doaj.org/article/467f06abf07c49b3a582117216f61f3f
Autor:
Craig I. Coleman, Olivia S. Costa, Stuart J. Connolly, Mukul Sharma, Jan Beyer-Westendorf, Mary J. Christoph-Schubel, Belinda Lovelace
Publikováno v:
Critical Care, Vol 27, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/4e44f0a675cb47fdb0520df4c3ddba7c
Publikováno v:
SSM: Population Health, Vol 4, Iss , Pp 135-143 (2018)
The last century has seen dramatic shifts in population work circumstances, leading to an increasing normalization of non-standard work schedules (NSWSs), defined as non-daytime, irregular hours. An ever-growing body of evidence links NSWSs to a host
Externí odkaz:
https://doaj.org/article/99ca72858b4847c4bdba82a0fdde8f67
Publikováno v:
Annals of Global Health, Vol 83, Iss 2, Pp 311-319 (2017)
Background: Uganda is experiencing a dual burden of over- and undernutrition, with overweight prevalence increasing while underweight remains common. Potential weight-related factors, particularly physical activity, sleep, and rural/urban status, are
Externí odkaz:
https://doaj.org/article/ee8de89f52c447f0961752e0e6b3ddb6
Autor:
S. Scott Sutton, Joseph Magagnoli, Tammy H. Cummings, Theresa Dettling, Belinda Lovelace, Mary J. Christoph, James W. Hardin
Publikováno v:
Journal of Thrombosis and Thrombolysis.
Oral factor Xa (FXa) inhibitors significantly reduce incidence of stroke and thromboembolic events in patients with atrial fibrillation or venous thromboembolism. Due to various factors and the lack of a randomized controlled trial comparing andexane
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89077b8a983512508423dcd30c66a0f5
https://doi.org/10.1007/s11239-023-02820-y
https://doi.org/10.1007/s11239-023-02820-y